CALR and breast carcinoma: In this experiment he also demonstrated that amplified ROS generation provoked a robust immune response at a physiological tolerable temperature below 40 °C in a hypoxic tumor microenvironment, promoting the CRT expression on 4T1 breast cancer cells, macrophage polarization to immunostimulatory M1 phenotypes, and T lymphocyte infiltration in tumors.